The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation

Human Immunology

Volumn 69, Issue 11, 2008, Pages 797-804

  Zozulya, Alla L ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Autoimmunity; CD8 regulatory T cells; Effector T cells; Neuroinflammation

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; DEMYELINATING DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS;

EID: 56349147554     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.07.014     Document Type: Article

References (69)

1. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
2. Weiner H.L., Hafler D.A., Fallis R.J., Johnson D., Ault K.A., and Hauser S.L. Altered blood T-cell subsets in patients with multiple sclerosis. J Neuroimmunol 6 (1984) 115-121
3. Forghani B., Cremer N.E., Johnson K.P., Fein G., and Likosky W.H. Comprehensive viral immunology of multiple sclerosis. III. Analysis of CSF antibodies by radioimmunoassay. Arch Neurol 37 (1980) 616-619
4. Zozulya A.L., and Wiendl H. The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 4 (2008) 384-398
5. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
6. Hafler D.A. Multiple sclerosis. J Clin Invest 113 (2004) 788-794
7. + T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
8. -/- mice. Science 256 (1992) 1210-1213
9. Linker R.A., Rott E., Hofstetter H.H., Hanke T., Toyka K.V., and Gold R. EAE in β-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol Dis 19 (2005) 218-228
10. - T cells in an autoimmune disease model. J Clin Invest 112 (2003) 1037-1048
11. + T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 35 (2005) 76-85
12. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194 (2001) 669-676
13. + T cells. Ann NY Acad Sci 1103 (2007) 157-166
14. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166 (2001) 7579-7587
15. Woodroofe M.N., Bellamy A.S., Feldmann M., Davison A.N., and Cuzner M.L. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 74 (1986) 135-152
16. Hauser S.L., Bhan A.K., Gilles F., Kemp M., Kerr C., and Weiner H.L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19 (1986) 578-587
17. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 12000;23:1174-83.
18. Neumann H., Medana I.M., Bauer J., and Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25 (2002) 313-319
19. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192 (2000) 393-404
20. + T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 101 (2004) 2428-2433
21. + T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125 (2002) 538-550
22. + T-cell in multiple sclerosis. Ann NY Acad Sci 756 (1995) 310-312
23. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130 (2007) 2789-2799
24. + T cells in multiple sclerosis: a new target for therapy?. Brain 128 (2005) 1747-1763
25. Pouly S., and Antel J.P. Multiple sclerosis and central nervous system demyelination. J Autoimmun 13 (1999) 297-306
26. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187 (1998) 1395-1402
27. Wilson J.D., Ogg G.S., Allen R.L., Goulder P.J., Kelleher A., Sewell A.K., et al. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med 188 (1998) 785-790
28. Fujinami R.S., von Herrath M.G., Christen U., and Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19 (2006) 80-94
29. + cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J Virol 76 (2002) 12834-12844
30. Lindsey J.W., Hodgkinson S., Mehta R., Mitchell D., Enzmann D., and Steinman L. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann Neurol 36 (1994) 183-189
31. Cornet A., Savidge T.C., Cabarrocas J., Deng W.L., Colombel J.F., Lassmann H., et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?. Proc Natl Acad Sci USA 98 (2001) 13306-13311
32. + T cells in a spontaneous model of demyelinating disease. J Immunol 177 (2006) 2403-2411
33. Cao Y., Toben C., Na S.Y., Stark K., Nitschke L., Peterson A., et al. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur J Immunol 36 (2006) 207-215
34. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 (2004) 4222-4231
35. Medana I., Martinic M.A., Wekerle H., and Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 159 (2001) 809-815
36. Fogdell-Hahn A., Ligers A., Gronning M., Hillert J., and Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55 (2000) 140-148
37. Harbo H.F., Lie B.A., Sawcer S., Celius E.G., Dai K.Z., Oturai A., et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63 (2004) 237-247
38. Miller A., Lider O., Roberts A.B., Sporn M.B., and Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 89 (1992) 421-425
39. -/- DBA/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol 141 (2003) 10-19
40. + T cells: analysis using depleting antibodies. J Autoimmun 23 (2004) 1-7
41. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., and Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5 (2004) 516-523
42. + suppressor T cells. J Clin Invest 114 (2004) 1218-1221
43. Dorf M.E., and Benacerraf B. Suppressor cells and immunoregulation. Annu Rev Immunol 2 (1984) 127-157
44. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
45. + regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200 (2004) 1123-1134
46. + T cells. IMs. J Immunol 175 (2005) 7093-7097
47. + regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol 20 (2008) 937-947
48. Feger U., Tolosa E., Huang Y.H., Waschbisch A., Biedermann T., Melms A., et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110 (2007) 568-577
49. Myers L., Croft M., Kwon B.S., Mittler R.S., and Vella A.T. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. J Immunol 174 (2005) 7625-7632
50. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
51. + tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068
52. Vlad G., Cortesini R., and Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 174 (2005) 5907-5914
53. Suciu-Foca N., Manavalan J.S., Scotto L., Kim-Schulze S., Galluzzo S., Naiyer A.J., et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol 5 (2005) 7-11
54. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195 (2002) 695-704
55. + T cells. J Immunol 177 (2006) 2775-2783
56. + regulatory T cells in multiple sclerosis. J Neuroimmunol 195 (2008) 121-134
57. + T cells in multiple sclerosis. J Immunol 176 (2006) 7119-7129
58. + cell lines from patients with progressive multiple sclerosis. J Immunol 137 (1986) 3436-3439
59. Bania M.B., Antel J.P., Reder A.T., Nicholas M.K., and Arnason B.G. Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2. J Clin Invest 78 (1986) 582-586
60. Correale J., Lund B., McMillan M., Ko D.Y., McCarthy K., and Weiner L.P. T cell vaccination in secondary progressive multiple sclerosis. J Neuroimmunol 107 (2000) 130-139
61. Zhang J., Medaer R., Stinissen P., Hafler D., and Raus J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261 (1993) 1451-1454
62. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., et al. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest 109 (2002) 641-649
63. Airas L., Nikula T., Huang Y.H., Lahesmaa R., and Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J Neuroimmunol 187 (2007) 205-211
64. + regulatory thymocytes. Blood 102 (2003) 4107-4114
65. + T cells with a regulatory phenotype and function. Eur J Immunol 35 (2005) 2896-2908
66. Noble A., Giorgini A., and Leggat J.A. Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 107 (2006) 4475-4483
67. + T cells is mediated by interferon-γ and is defective in chronic progressive multiple sclerosis. J Clin Invest 95 (1995) 2711-2719
68. Fukaura H., Kent S.C., Pietrusewicz M.J., Khoury S.J., Weiner H.L., and Hafler D.A. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98 (1996) 70-77
69. + regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol 172 (2004) 1531-1539